LivaNova PLC (LIVN) stock
LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3032% above fair value
$94.54+2.62 (+2.85%)
Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –
LivaNova total assets
Total assets on the balance sheet at the end of each period.
LivaNova's total assets was $2.64B at Jun 30, 2026. For fiscal 2025 it was $2.61B, up 4.0% from the year before. Over ten years it grew 24.4% a year on average. The highest annual figure on record is $2.61B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.61B | +4.0% |
| FY2024 | Dec 31, 2024 | $2.51B | +3.2% |
| FY2023 | Dec 31, 2023 | $2.43B | +5.9% |
| FY2022 | Dec 31, 2022 | $2.29B | +4.3% |
| FY2021 | Dec 31, 2021 | $2.20B | -8.3% |
| FY2020 | Dec 31, 2020 | $2.40B | -0.5% |
| FY2019 | Dec 31, 2019 | $2.41B | -5.4% |
| FY2018 | Dec 31, 2018 | $2.55B | +1.8% |
| FY2017 | Dec 31, 2017 | $2.50B | +692.5% |
| FY2015 | Apr 24, 2015 | $315.94M | +7.4% |
| FY2014 | Apr 25, 2014 | $294.19M | +11.4% |
| FY2013 | Apr 26, 2013 | $264.04M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $2.64B | +5.4% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $2.52B | -1.7% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $2.61B | +4.0% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $2.56B | +1.4% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $2.51B | +2.2% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $2.56B | +4.0% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $2.51B | +3.2% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $2.52B | +8.3% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $2.45B | +4.8% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $2.46B | +7.2% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $2.43B | +5.9% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $2.33B | +5.3% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $2.34B | +0.2% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $2.29B | -5.0% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $2.29B | +4.3% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $2.21B | +0.4% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $2.34B | -2.5% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $2.42B | +2.0% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $2.20B | -8.3% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $2.20B | -12.6% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $2.40B | -4.2% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $2.37B | -3.5% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $2.40B | -0.5% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $2.52B | +0.5% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $2.50B | -4.5% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $2.45B | -5.6% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $2.41B | -5.4% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $2.51B | -3.9% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $2.62B | +0.9% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $2.60B | -3.9% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $2.55B | +1.8% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $2.61B | +0.3% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $2.60B | +2.5% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $2.70B | +14.1% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $2.50B | +692.5% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $2.60B | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | $2.53B | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | $2.37B | – |
| Q4 FY2015CQ1 2015 | Apr 24, 2015 | $315.94M | – |
See a number that looks wrong?